1.0HIV and ID Observationshttps://blogs.nejm.org/hiv-id-observationsPaul Saxhttps://blogs.nejm.org/hiv-id-observations/index.php/author/paul-sax/Tesamorelin is Approvedrich600338<blockquote class="wp-embedded-content" data-secret="WlZnjNrRCv"><a href="https://blogs.nejm.org/hiv-id-observations/index.php/tesamorelin-is-approved/2010/11/12/">Tesamorelin is Approved</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://blogs.nejm.org/hiv-id-observations/index.php/tesamorelin-is-approved/2010/11/12/embed/#?secret=WlZnjNrRCv" width="600" height="338" title="“Tesamorelin is Approved” — HIV and ID Observations" data-secret="WlZnjNrRCv" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://blogs.nejm.org/hiv-id-observations/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
This just in from the FDA: The U.S. Food and Drug Administration today approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs. The condition is associated with many antiretroviral drugs used to […]http://blogs.nejm.org/hiv-id-observations/wp-content/uploads/sites/2/2010/11/sesame_street_bigbird1.png